- Home
- AIFF vs OKYO Comparison
AIFF vs OKYO Comparison
Compare AIFF & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIFF
- OKYO
- Stock Information
- Founded
- AIFF 2006
- OKYO 2007
- Country
- AIFF United States
- OKYO United Kingdom
- Employees
- AIFF N/A
- OKYO N/A
- Industry
- AIFF
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AIFF
- OKYO Health Care
- Exchange
- AIFF NYSE
- OKYO Nasdaq
- Market Cap
- AIFF 37.9M
- OKYO 37.0M
- IPO Year
- AIFF N/A
- OKYO 2022
- Fundamental
- Price
- AIFF $3.03
- OKYO $2.78
- Analyst Decision
- AIFF
- OKYO Strong Buy
- Analyst Count
- AIFF 0
- OKYO 1
- Target Price
- AIFF N/A
- OKYO $7.00
- AVG Volume (30 Days)
- AIFF 1.6M
- OKYO 217.1K
- Earning Date
- AIFF 08-18-2025
- OKYO 08-12-2025
- Dividend Yield
- AIFF N/A
- OKYO N/A
- EPS Growth
- AIFF N/A
- OKYO N/A
- EPS
- AIFF N/A
- OKYO N/A
- Revenue
- AIFF $139,000.00
- OKYO N/A
- Revenue This Year
- AIFF N/A
- OKYO N/A
- Revenue Next Year
- AIFF N/A
- OKYO N/A
- P/E Ratio
- AIFF N/A
- OKYO N/A
- Revenue Growth
- AIFF N/A
- OKYO N/A
- 52 Week Low
- AIFF $1.86
- OKYO $0.81
- 52 Week High
- AIFF $17.20
- OKYO $3.11
- Technical
- Relative Strength Index (RSI)
- AIFF 55.14
- OKYO 63.68
- Support Level
- AIFF $2.70
- OKYO $2.05
- Resistance Level
- AIFF $3.09
- OKYO $2.92
- Average True Range (ATR)
- AIFF 0.25
- OKYO 0.29
- MACD
- AIFF 0.03
- OKYO 0.02
- Stochastic Oscillator
- AIFF 47.74
- OKYO 68.87
About AIFF FIREFLY NEUROSCIENCE INC
Firefly Neuroscience Inc is an AI company developing neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support outcomes for people suffering from mental illnesses and cognitive disorders. The Company has one reportable segment: the BNA platform. The Company derives revenue from North America.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.